PTEN and prostate carcinoma: In addition to the PTEN-controlled TFAs derived from the inducible PtenΔloxp/Δloxp MEFs, we identified another 19 TFs whose activities are significantly perturbed in the Pten null prostate cancer mouse model (Figure S2).